Fast-Track Protocol for Endovascular Aneurysm Repair (EVAR) of Infrarenal Abdominal Aortic Aneurysms (NCT07431047) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Fast-Track Protocol for Endovascular Aneurysm Repair (EVAR) of Infrarenal Abdominal Aortic Aneurysms
50 participantsStarted 2026-02-11
Plain-language summary
The study aims to evaluate the clinical and economic efficacy of a "Fast-Track" protocol for the elective endovascular treatment (EVAR) of infrarenal abdominal aortic aneurysms (AAA). The protocol minimizes invasiveness through the use of local/locoregional anesthesia, a total percutaneous approach, and the avoidance of routine Intensive Care Unit (ICU) admission. The primary goal is to reduce hospital Length of Stay (LOS) to \<48 hours and decrease procedural costs, while maintaining safety and increasing patient turnover compared to the standard of care.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
* Patient diagnosed with infrarenal Abdominal Aortic Aneurysm (AAA) indicated for elective endovascular repair.
* Patient diagnosed with Penetrating Aortic Ulcer (PAU) indicated for elective endovascular repair.
* Patient resident in the Bologna metropolitan area OR able to remain within the area for at least 7 days post-procedure.
* Patient with a cohabitant or caregiver available (cannot live alone) to ensure safety during the early post-discharge phase.
* Signed informed consent specifically for local/locoregional anesthesia, the procedure and the specific fast-track pathway.
* Common femoral arteries diameter \> 7 mm
* Common femoral arteries free of severe calcification (\< 50% of vessel circumference), suitable for percutaneous closure device
* Proximal aortic neck length \> 15 mm
* Proximal aortic neck diameter \< 30 mm
* Proximal aortic neck without severe angulation (\<60°) or circumferential thrombus \<50%
Exclusion Criteria:
* Patient resident outside the Bologna metropolitan area or unable to remain within the area for at least 7 days post-procedure.
* Patient without a cohabitant or caregiver available
* Common femoral arteries diameter \<7 mm
* Common femoral arteries with severe calcification (\> 50% of vessel circumference), unsuitable for percutaneous closure device
* Proximal aortic neck length \< 15 mm
* Proximal aortic neck diameter \> 30 mm
* Proximal aortic neck with severe angulation (\>60°) or circumferential thrombus \>50%
* Gene…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.